Bosch-Rué Elia, Zhang Qiao, Truskey George A, Olmos Buitrago Jenifer, M Bosch Begoña, Pérez Román A
Bioengineering Institute of Technology (BIT), Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, 08195 Barcelona, Spain.
Bioengineering Department, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, 08195 Barcelona, Spain.
Biofabrication. 2025 May 27;17(3). doi: 10.1088/1758-5090/add626.
Since the first tissue engineered blood vessel (TEBV) was developed, different approaches, biomaterial scaffolds and cell sources have been used to obtain an engineered vessel as much similar as native vessels in terms of structure, functionality and mechanical properties. At the same time, diverse needs to obtain a functional TEBV have emerged, such as for blood vessel replacement for cardiovascular diseases (CVDs) to be used as artery bypass, to vascularize tissue engineered constructs, or even to model vascular diseases or drug testing. In this review, after briefly describing the native structure and function of arteries, we will give an overview of different biomaterials, cells and methods that have been used during the last years for the development of small TEBV (1-6 mm diameter). The importance of perfusing the TEBV to acquire functionality and maturation will be also discussed. Finally, we will center the review on TEBV applications beyond their use as vascular graft for CVDs.
自从首个组织工程血管(TEBV)问世以来,人们采用了不同的方法、生物材料支架和细胞来源,以期获得在结构、功能和力学性能方面尽可能与天然血管相似的工程血管。与此同时,出现了对功能性TEBV的多种需求,比如用于心血管疾病(CVD)的血管置换,作为动脉搭桥使用,为组织工程构建体提供血管化,甚至用于模拟血管疾病或药物测试。在本综述中,在简要描述动脉的天然结构和功能之后,我们将概述过去几年中用于开发小口径TEBV(直径1 - 6毫米)的不同生物材料、细胞和方法。还将讨论灌注TEBV以获得功能和成熟度的重要性。最后,我们将把综述重点放在TEBV在用作CVD血管移植物之外的应用上。